Jun Yuan Wang

Director/Miembro de la Junta en NUVATION BIO INC. .

Fortuna: 5 M $ al 30/04/2024

51 años

18 relaciones

Consumer Services

Commercial Services

Health Technology

Perfil

Jun Yuan Wang is the founder of AnHeart Therapeutics (Hangzhou) Co., Ltd., where he holds the title of General Manager & Director.
He founded the company in 2018.
Dr. Wang is currently working as a Director at Nuvation Bio, Inc. since 2024.
In terms of education, Dr. Wang holds a doctorate degree from Iowa State University and an undergraduate degree from the University of Science & Technology of China.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
NUVATION BIO, INC. CLASS A 0.89%	15/04/2024	1 929 747 ( 0.89% )	5 M $	30/04/2024

Cargos activos de Jun Yuan Wang

Empresas	Cargo	Inicio
NUVATION BIO INC.	Director/Miembro de la Junta	09/04/2024
AnHeart Therapeutics (Hangzhou) Co., Ltd. AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China.	Fundador	27/11/2018

Todos los cargos activos de Jun Yuan Wang

Formación de Jun Yuan Wang.

University of Science & Technology of China	Undergraduate Degree
Iowa State University	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jun Yuan Wang.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
NUVATION BIO INC.	Health Technology

Empresas privadas	1
AnHeart Therapeutics (Hangzhou) Co., Ltd. AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China.	Commercial Services